GlassScriptPhysician profile
Mohammad-Ali Shaikh
NPI 1932633476
$2,536.96
in general payments reported to CMS, 2019-2025
12 companies · $401 in 2025
The $401 reported for 2025 was more than what 81% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
See the full distribution for Critical Care Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $70.38 · 2023: $1,016 · 2024: $1,049 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,466.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $903.99 | 2023-2024 | Impella |
| Abbott Laboratories | $303.54 | 2023-2025 | 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit, Proclaim |
| Eagle Pharmaceuticals, INC. | $265.25 | 2023 | |
| La Jolla Pharmaceutical Company | $261.20 | 2023-2025 | Giapreza |
| Bolton Medical INC | $165.65 | 2025 | Treo Abdominal Stent-Graft System |
| Xtant Medical INC | $161.58 | 2023 | |
| Alexion Pharmaceuticals, INC. | $123.36 | 2023 | |
| Chiesi USA, INC. | $115.43 | 2023 | Cleviprex |
| Curonix LLC | $72.96 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $70.38 | 2022 | |
| Spr Therapeutics, INC | $52.51 | 2025 | Sprint Pns System |
| Painteq LLC | $41.11 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad-Ali Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.